Results 61 to 70 of about 299,239 (347)
Drug-drug interaction with oral antivirals for the early treatment of COVID-19
International Journal of Infectious Diseases, 2023 Non peer ...
Alpo Vuorio +2 more
openaire +4 more sources
Drug repurposing against coronavirus disease 2019 (COVID-19): A review
Journal of Pharmaceutical Analysis, 2021 Since December 2019, severe acute respiratory syndrome coronavirus 2 has been found to be the culprit in the coronavirus disease 2019 (COVID-19), causing a global pandemic. Despite the existence of many vaccine programs, the number of confirmed cases and
Lianxiang Luo +8 more
doaj
Antimicrobial Stewardship & Healthcare Epidemiology, 2023 Background: Prescribing errors related to the COVID-19 oral antiviral agent nirmatrelvir-ritonavir have been reported and are primarily due to improper renal dosing and significant drug–drug interactions.
Jenna Preusker +8 more
doaj +1 more source
Antiviral Drug Discovery for the Treatment of COVID-19 Infections
Viruses, 2022 The coronavirus disease 2019 (COVID-19) pandemic is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a recently emerged human coronavirus. COVID-19 vaccines have proven to be successful in protecting the vaccinated from infection, reducing the severity of disease, and deterring the transmission of infection. However, COVID-19
Teresa I. Ng +7 more
openaire +3 more sources
Experimental Results, 2020 Potential clinically significant life-threatening drug–drug interactions (DDIs) of lopinavir (LPV) and ritonavir (RTV) used in the treatment of COVID-19 is not systematically reviewed.
Mohitosh Biswas, Martin Michaelis
doaj +1 more source
A mini-review on the current COVID-19 therapeutic strategies [PDF]
Chemical Review and Letters, 2020 The coronavirus outbreak (COVID-19) started in china, on 31 December 2019. COVID-19 is a severe acute respiratory syndrome. Research on COVID-19 treatment strategies for development of an effective drug therapy has attracted worldwide attention recently.
Samira Shafiee, Soodabeh Davaran
doaj +1 more source
The Impact of Covid-19 on Future Higher-Age Mortality [PDF]
, 2020 Covid-19 has predominantly affected mortality at high ages. It kills by inflaming and clogging the air sacs in the lungs, depriving the body of oxygen ‒ inducing hypoxia ‒ which closes down essential organs, in particular the heart, kidneys and liver ...
Blake, D. +3 more
core
An Overview of Repurposed Drugs for Potential COVID-19 Treatment
Antibiotics, 2022 The COVID-19 pandemic caused by SARS-CoV-2 has placed severe constraints on healthcare systems around the globe. The SARS-CoV-2 virus has caused upheaval in the healthcare and economic sectors worldwide. On the 20th of May 2020, the World Health Organisation declared COVID-19 a global pandemic due to the unprecedented number of cases reported around ...
Kamini Govender, Anil Chuturgoon
openaire +3 more sources
Prevention and treatment of ventilator-associated pneumonia in COVID-19
Frontiers in Pharmacology, 2022 Ventilator-associated pneumonia (VAP) is the most common acquired infection in the intensive care unit. Recent studies showed that the critical COVID-19 patients with invasive mechanical ventilation have a high risk of developing VAP, which result in a ...
Jiayi Deng +4 more
doaj +1 more source
Potential Drug Candidates in Clinical Trials for the Treatment of Covid-19: An Updated Overview [PDF]
, 2021 The coronavirus (SARS-CoV-2) emerged in December 2019 in Wuhan, China and by the end of April 2020, it spread to more than 200 countries worldwide. Particularly the USA, Brazil, Spain, Italy, France, Germany, UK, Turkey, Iran, and Russia were the most ...
Cáceres, Osmar Ignacio Ayala +6 more
core +2 more sources